Univ Paris-Sud, Laboratoire des Enveloppes Bactériennes et Antibiotiques, UMR 8619, Orsay, F-91405, France.
Biochem Pharmacol. 2012 Sep 1;84(5):625-32. doi: 10.1016/j.bcp.2012.06.006. Epub 2012 Jun 15.
D-Glutamic acid-adding enzyme (MurD ligase) catalyses the addition of D-glutamic acid to UDP-N-acetylmuramoyl-L-alanine, an essential cytoplasmic step in the pathway for bacterial cell-wall peptidoglycan synthesis. As such, it represents an important antibacterial drug-discovery target enzyme. Recently, several series of compounds have been synthesised and found to inhibit MurD from Escherichia coli, the best one having an IC(50) value of 8 μM. In the present work, we have tested 20 of these compounds against the MurD enzymes from Staphylococcus aureus, Streptococcus pneumoniae, Borrelia burgdorferi and Mycobacterium tuberculosis. Most of the E. coli MurD inhibitors appeared less efficient against the four other orthologues. This divergent result can be explained by the differences in amino acid sequences and topologies of the active sites of the MurD ligases studied.
D-谷氨酸添加酶(MurD 连接酶)催化 D-谷氨酸与 UDP-N-乙酰基胞壁酰-L-丙氨酸的结合,这是细菌细胞壁肽聚糖合成途径中的一个必要的细胞质步骤。因此,它代表了一个重要的抗菌药物发现靶酶。最近,已经合成了几个系列的化合物,并发现它们可以抑制来自大肠杆菌的 MurD,其中最好的一个化合物的 IC(50)值为 8 μM。在本工作中,我们已经测试了 20 种这些化合物对来自金黄色葡萄球菌、肺炎链球菌、伯氏疏螺旋体和结核分枝杆菌的 MurD 酶的抑制作用。大多数大肠杆菌 MurD 抑制剂对其他四种同源物的效果较差。这种不同的结果可以通过研究的 MurD 连接酶的活性位点的氨基酸序列和拓扑结构的差异来解释。